AzTrials
AzTrials

Health Informatics EducationHI-EDUNCT07690241

Health Informatics Education Effectiveness in Nepal

A study testing Health Informatics-471 Blended Course in people with Health Informatics Education, run by Axon Infotech Research Academy Pvt. Ltd. at 1 site in Nepal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates the effectiveness of a blended Health Informatics (HI) course (HI471) on knowledge retention and technology awareness among health science students in Nepal. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Health Informatics Education
What is being tested?
Health Informatics-471 Blended Course
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteNepal
Study dates
15 Apr 2026to 30 Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Active enrollment in the 7th semester of the Bachelor of Public Health (BPH) program (intervention group) or the Bachelor of Pharmacy (B.Pharm) program (control group) at Madan Bhandari Academy of Health Sciences (MBAHS).
  • Voluntary written informed consent obtained prior to any study procedure.
  • Completion of both T1 (Week 1, baseline) and T2 (Week 15, post-intervention) assessments.

Who cannot join

  • Withdrawal from the study before completion of all study procedures.
  • Incomplete paired data (missing T1 or T2 assessment).

Trial locations and contacts

1 site in 1 country.

Nepal1 site
  • Madan Bhandari Academy of Health Sciences

    Hetauda, Bagmati, 31206

Other trials in Nepal

About this study

Official title: Assessing the Comparative Effectiveness of Health Informatics Education: Knowledge Retention and Technological Awareness in Health Science Students

This study evaluates the effectiveness of a blended Health Informatics (HI) course (HI471) on knowledge retention and technology awareness among health science students in Nepal. Bachelor of Public Health (BPH) students (intervention group, n=17) received a 14-week HI471 course combining online, virtual, and in-person practical sessions. A control group of Bachelor of Pharmacy (B.Pharm) students (n=17) continued their standard curriculum without dedicated HI instruction. Both groups completed a validated 44-item knowledge assessment and an 11-item technology awareness survey at baseline (Week 1) and post-intervention (Week 15). The primary outcome was the between-group difference in knowledge gain scores. Results showed that BPH students significantly improved their total knowledge scores (median +31.5 points, r=0.879), while the B.Pharm control group showed no significant change. BPH students achieved 100% awareness of 9 out of 11 digital health tools at post-test. This study provides strong evidence that the HI471 blended course is highly effective in building informatics competencies in a low- and middle-income country (LMIC) academic setting. The study was retrospectively registered.

Read the detailed description

This controlled pre-test/post-test quasi-experimental study with a non-equivalent control group evaluated the effectiveness of the Health Informatics-471 (HI471) blended course at Madan Bhandari Academy of Health Sciences (MBAHS) in Nepal. The intervention group (G1) consisted of all 17 Bachelor of Public Health (BPH) students enrolled in the 7th semester, who received the HI471 course. The control group (G2) consisted of 17 Bachelor of Pharmacy (B.Pharm) 7th-semester students, randomly sampled from 29 eligible students, who received no dedicated HI instruction. The HI471 course integrated three blended modalities over 14 weeks: (i) online asynchronous LMS instruction (pre-recorded lectures, readings, quizzes), (ii) live synchronous Google Meet sessions, and (iii) in-person practical laboratory sessions covering EHR platforms, DHIS2, SPSS/R, and telemedicine interfaces. A validated 44-item Health Informatics Knowledge Assessment Tool (with weighted partial-credit scoring, maximum 100 points) and an 11-item binary technology awareness instrument were administered at T1 (Week 1, baseline) and T2 (Week 15, post-intervention). The primary outcome was the between-group difference in total knowledge gain scores (Δ = T2 - T1), analyzed using non-parametric statistics (Mann-Whitney U, Wilcoxon signed-rank, Friedman, McNemar) with bootstrap effect sizes. The study demonstrated large, significant knowledge gains in the intervention group (median +31.5 points, r=0.824, p<0.001) compared to the control group, with robust findings across three pre-specified sensitivity analyses. The intervention group achieved near-complete technology awareness (100% on 9 out of 11 tools). This research addresses the evidence gap for controlled educational evaluations in low- and middle-income country (LMIC) academic settings. The study protocol was approved by the MBAHS Institutional Review Committee (IRC-134-082-083), and all participants provided written informed consent. The study was conducted in compliance with the Declaration of Helsinki (revised 2013). The study was registered retrospectively.

Being tested
Health Informatics-471 Blended Course

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Health Informatics-471 Blended CourseOther

    A 14-week blended educational course combining: (i) online asynchronous LMS instruction (pre-recorded lectures, readings, quizzes); (ii) live synchronous Google Meet sessions (2 hours, 3 days per week); and (iii) in-person practical laboratory sessions (4 hours per week) covering Electronic Health Records (EHR), DHIS2, SPSS/R, and telemedicine interfaces. No drug, device, biological product, or surgical procedure was involved. This is a purely educational/behavioral intervention delivered in an academic setting.

Study groups in NCT07690241
Study groupRoleWhat they receive
BPH Intervention GroupExperimentalBachelor of Public Health (BPH) 7th-semester students (n=17) who received the 14-week Health Informatics-471 (HI471) blended course, consisting of online asynchronous LMS instruction, live synchronous Google Meet sessions, and in-person practical laboratory work covering seven HI content domains.
Receives: Other: Health Informatics-471 Blended Course
B.Pharm Control GroupNo interventionBachelor of Pharmacy (B.Pharm) 7th-semester students (n=17) who continued their standard curriculum without any dedicated Health Informatics instruction. This group served as the non-equivalent control group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Total Health Informatics Knowledge Score

    Measured using the Health Informatics Knowledge Assessment Tool (HIKAT) - a validated 44-item multiple-select instrument with weighted partial-credit scoring. Scores range from 0 to 100 points, where higher scores indicate better health informatics knowledge. Administered to both groups at T1 (Week 1, pre-test) and T2 (Week 15, post-test). The primary causal contrast is the between-group difference in gain scores (Δ = T2 - T1), analyzed using Mann-Whitney U test with bootstrapped effect sizes.

    Measured: Baseline (Week 1) to post-intervention (Week 15)

Secondary outcomes (1)
  1. Domain-Specific Knowledge Gains Across Six HI Content Areas

    Change in knowledge scores across six domain areas assessed using the Health Informatics Knowledge Assessment Tool (HIKAT): D1 General HI/Introduction to IT, D2 Operating Systems \& Software, D3 Public Health \& IT, D4 Database Management, D5+6 Data Analysis \& Coding, and D7 Telemedicine. Each domain score is expressed as a percentage of the domain maximum (minimum: 0%, maximum: 100%), where higher scores indicate greater domain-specific health informatics knowledge. Domain gains are analyzed using Friedman test with Kendall W and Holm-corrected post-hoc Wilcoxon signed-rank tests within the intervention group.

    Measured: Baseline (Week 1) to post-intervention (Week 15)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2026
  2. Study start15 Apr 2026
  3. Primary completion20 Jun 2026
  4. Study completion30 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Two parallel groups: BPH intervention group and B.Pharm control group, assessed at baseline and post-intervention (15 weeks).
Masking
None (open label)
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07690241
Sponsor's protocol ID
HI471-MBAHS-2026
Other IDs
IRC-134-082-083
Acronym
HI-EDU
Status last verified
Jul 2026
First submitted
2 Jul 2026
Last updated
8 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared because participants did not provide consent for their individual-level data to be shared with external researchers. Additionally, the small sample size (n=34) increases the risk of participant re-identification, even with de-identification. All aggregated, anonymized summary data are presented in the published manuscript and supplementary materials

Questions about this trial

What is this clinical trial studying?

A study testing Health Informatics-471 Blended Course in people with Health Informatics Education, run by Axon Infotech Research Academy Pvt. Ltd. at 1 site in Nepal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Nepal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Total Health Informatics Knowledge Score (time frame: Baseline (Week 1) to post-intervention (Week 15)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in